Is Dyne Therapeutics, Inc. overvalued?

Dyne Therapeutics, Inc. (DYN) — key valuation metrics and fundamentals.

No verdict

Price

$16.03

Fair value

—

Current P/E

—

Normal P/E

45.0

Market cap

$2.99B

Dividend yield

0.0%

Return on equity

-64.3%

Sector

Healthcare

Fair value compares DYN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks